Search Results
Viewing: 231-240 of 283 | All
News
Nationwide Children’s Hospital Announces Expanded Facility and Therapy Dog Program
Nationwide Children’s Hospital announced today Butterfly PAWS, an expanded facility and therapy dog program to support healing, and emotional and mental well-being and contribute to best outcomes for patients, families and staff. To celebrate Butterfly PAWS, the hospital unveiled “Canine Corner,” a special area on the first floor of the hospital featuring seating for families during their visit, animal friends Gus and Junebug and a digital display dedicated to highlighting pups and patients alike.
Article
Kopp Lab
Our lab is dedicated to helping children and young adults with chronic lung diseases, especially cystic fibrosis (CF) and sickle cell disease (SCD), breathe easier and stay healthier.
News
Nationwide Children’s Hospital Launches ‘Light Up the Lawn, Light Up a Life’ to Brighten Lives of Patients in the Hospital for the Holidays
Nationwide Children’s Hospital is launching “Light Up the Lawn, Light Up a Life” – a new holiday tradition that builds hope and joy for hospitalized children, families and the health care heroes caring for them.
News
Epilepsy Centers in United States Expand in Size and Specialized Testing Services with Accreditation
New research from the Abigail Wexner Research Institute at Nationwide Children’s Hospital has found that as a result of the increased number of accredited epilepsy centers in the United States, drug-resistant epilepsy (DRE) patients have easier access to specialized testing and services. The report, which describes level 3 and level 4 epilepsy centers that were accredited by the National Association of Epilepsy Centers (NAEC) from 2012 to 2019, published this week in Neurology.
News
Probiotics Delivered in Biofilm State Protect the Intestines and Brain in NEC Model
Researchers at Nationwide Children’s have been working on a novel solution to prevent NEC. They have developed a novel probiotic system that harnesses the durability of biofilms to improve the administration of probiotics to patients. It has been licensed to Scioto Biosciences. Their latest study, published in Nature Scientific Reports, describes the use of a biofilm formulation of Limosilactobacillus reuteri (Lr) to prevent NEC in a piglet model.
Article
Gerhardt Lab Staff
Learn more about principal investigator Cynthia Gerhardt, PhD, and her dynamic team in the Gerhardt Lab.
News
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
Article
Interprofessional Education and Grand Rounds Update
- Upcoming Conferences
- Pediatric Grand Rounds
News
Nationwide Children’s Hospital Joins New NORD Rare Disease Centers of Excellence Network, Committed to Improving Access and Care for Rare Disease Patients
Nationwide Children’s Hospital has been selected as a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD), a nonprofit patient advocacy organization committed to the identification, treatment and cure of rare disorders through education, research and patient services
Article
Frequently Asked Questions
Frequently asked questions about giving to Nationwide Children's Hospital.